AU6514400A - Method of identifying urotensin ii receptor antagonists - Google Patents

Method of identifying urotensin ii receptor antagonists

Info

Publication number
AU6514400A
AU6514400A AU65144/00A AU6514400A AU6514400A AU 6514400 A AU6514400 A AU 6514400A AU 65144/00 A AU65144/00 A AU 65144/00A AU 6514400 A AU6514400 A AU 6514400A AU 6514400 A AU6514400 A AU 6514400A
Authority
AU
Australia
Prior art keywords
urotensin
identifying
receptor antagonists
antagonists
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU65144/00A
Inventor
Olivier Civelli
Hans-Peter Nothacker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Publication of AU6514400A publication Critical patent/AU6514400A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/5751—Corticotropin releasing factor [CRF] (Urotensin)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU65144/00A 1999-08-24 2000-08-03 Method of identifying urotensin ii receptor antagonists Abandoned AU6514400A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37996899A 1999-08-24 1999-08-24
US09379968 1999-08-24
PCT/US2000/021171 WO2001014888A1 (en) 1999-08-24 2000-08-03 Method of identifying urotensin ii receptor antagonists

Publications (1)

Publication Number Publication Date
AU6514400A true AU6514400A (en) 2001-03-19

Family

ID=23499422

Family Applications (1)

Application Number Title Priority Date Filing Date
AU65144/00A Abandoned AU6514400A (en) 1999-08-24 2000-08-03 Method of identifying urotensin ii receptor antagonists

Country Status (2)

Country Link
AU (1) AU6514400A (en)
WO (1) WO2001014888A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10131458A1 (en) 2001-06-29 2003-01-09 Aventis Pharma Gmbh Process for the identification of connections for the therapy of aging processes of the cardiovascular system

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10501420A (en) * 1994-06-14 1998-02-10 ニューロクライン バイオサイエンシズ，インコーポレイティド Adrenocorticotropic hormone-releasing factor (2) Receptor
US6159700A (en) * 1997-01-27 2000-12-12 Smithkline Beecham Corporation Method of finding agonist and antagonist to human and rat GPR14
US5851798A (en) * 1997-01-27 1998-12-22 Smithkline Beecham Corporation Nucleic acid encoding human GPR14 receptor
WO1999035266A2 (en) * 1998-01-09 1999-07-15 Smithkline Beecham Corporation Human urotensin ii

Also Published As

Publication number Publication date
WO2001014888A1 (en) 2001-03-01

Similar Documents

Publication Publication Date Title
EP1223224A4 (en) Method of assaying glycoprotein
AU2441801A (en) Urotensin-ii receptor antagonists
GB9922352D0 (en) Screening method
AU3958902A (en) Crf receptor antagonists and methods relating thereto
AU1296899A (en) Phenyl-alkyl-imidazoles as h3 receptor antagonists
AU5861900A (en) Receptor agonists and antagonists
AU4980999A (en) A3 adenosine receptor antagonists
GB9923075D0 (en) Screening method
EP1237001A4 (en) Screening method
EP1137938A4 (en) Methods of screening for agonists and antagonists of the hdpxu17 receptor
AU6429000A (en) Screening method
AU6514400A (en) Method of identifying urotensin ii receptor antagonists
AU7820598A (en) Cembranoid inhibitors of nicotinic acetylcholine receptors
GB9904401D0 (en) Assay method
PL341752A1 (en) Method of obtaining aryloamino hydroxyantraquinones
GB9924752D0 (en) Method of construction
AU6826498A (en) Endotholin receptor antagonists
AU6826698A (en) Endothelin receptor antagonists
AU2872501A (en) Screening method
GB9928882D0 (en) Assay method
GB9930255D0 (en) Screening method
AU8241298A (en) Method for identifying modifiers of the leptin: leptin receptor interaction
AU6726400A (en) Screening method
AU2003201351A1 (en) CRF receptor antagonists and methods relating thereto
IL137538A0 (en) Method for preparing sulfanyl-type endothelin receptor antagonists

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase